Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants

17 Feb 2022

Abstract excerpt

IMPORTANCE: Screening mammography and magnetic resonance imaging (MRI) are recommended for women with ATM, CHEK2, and PALB2 pathogenic variants. However, there are few data to guide screening regimens for these women. OBJECTIVE: To estimate the benefits and harms of breast cancer screening strategies using mammography and MRI at various start ages for women with ATM, CHEK2, and PALB2 pathogenic variants. DESIGN,...

Source

Identifiers

PMID: 35175286
DOI: 10.1001/jamaoncol.2021.6204

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic VariantsPMID 35175286Read ↗

Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers.Semantic proximity Read ↗

Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.Semantic proximity Read ↗

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.Semantic proximity Read ↗

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.Semantic proximity Read ↗

Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2.Semantic proximity Read ↗

Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network.Semantic proximity Read ↗

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.Semantic proximity Read ↗

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk.Semantic proximity Read ↗

Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk.Semantic proximity Read ↗

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.Semantic proximity Read ↗

Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.Semantic proximity Read ↗

Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2, and PALB2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.